Expert Panel Talks over Yakkasa, Revamp of Price Revision Method; Fixed Margin, Claw-Back Mooted

March 20, 2023
Japan’s current drug price revision mechanism inevitably creates a gap between an NHI price and a market price, called yakkasa , which has effectively become a source of revenue particularly for pharmacies. Many members of a key health ministry expert...read more